Clinical Trial: An Investigational Trial to Evaluate the Effects of the Drug XC001 Delivered Via an Endocardial Delivery Catheter in Subjects With Chronic Angina Caused by Coronary Artery Disease

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07048808) titled 'An Investigational Trial to Evaluate the Effects of the Drug XC001 Delivered Via an Endocardial Delivery Catheter in Subjects With Chronic Angina Caused by Coronary Artery Disease' on June 24.

Brief Summary: This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD.

Part 1 of the study is comprised of 3 subjects with RA (CCS class II-IV) who will receive 4x1011 viral particles (vp) XC001. An Indepen...